.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Dow
Argus Health
Citi
Daiichi Sankyo
Healthtrust
Medtronic
Mallinckrodt
Express Scripts

Generated: December 17, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 9508538

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
AstrazenecaIRESSAgefitinibTABLET;ORAL021399-001May 5, 2003DISCNNoNo► Subscribe► SubscribeYYTREATMENT OF NON-SMALL CELL LUNG CANCER
Astrazeneca PharmsIRESSAgefitinibTABLET;ORAL206995-001Jul 13, 2015RXYesYes► Subscribe► SubscribeYYFIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) WHOSE TUMORS HAVE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) EXON 19 DELETIONS OR EXON 21 (L858R) SUBSTITUTION MUTATIONS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist